Raleigh-Durham-Chapel Hill Area
In the pharmaceutical industry, we have the rare privilege of changing — and often saving — lives for patients who might otherwise have no options. That mission has guided every step of my 25-year career.I began in sales, where I learned to truly listen to HCPs and patients, then spent the last 15+ years translating deep customer and market insights into high-impact global and U.S. marketing strategies. What energizes me most is working in environments where we ground decisions in rich insights, align quickly on a clear, focused strategy, and then empower strong teams to execute with real ownership and efficiency — tackling opportunities decisively while staying fully accountable to results. As Principal of Ting Consulting and through recent leadership roles at Biogen (Alzheimer’s Disease diagnostics & care pathway), UCB Pharma (Developmental Epileptic Encephalopathies), and Bio Products Laboratory (ultra-rare hematology, immunology & oncology), I partner with executive leadership to design and execute transformative go-to-market strategies and brand revitalizations. Through close collaboration with teams across Europe, LATAM, and Asia, I adapt insights and solutions to local market dynamics, regulatory environments, and patient needs while driving meaningful commercial success and broader disease awareness. Highlights include: - Leading global brand strategy and cross-functional launch teams for ultra-rare and neurologic conditions - Revitalizing mature brands and repositioning them for renewed growth - Directing large-scale product launches and building the first globally aligned marketing campaigns - Expanding diagnosis-to-treatment pathways through strategic partnerships and patient support services — especially for rare-disease communities whose voices are too often overlooked My leadership approach is straightforward: start with sharp customer and market insights, align on vision and priorities, give capable people real autonomy to deliver, and hold ourselves accountable to clear outcomes. I’ve seen this style consistently turn complex challenges into focused, high-impact wins across rare diseases, neurology, oncology, and beyond. I’m seeking opportunities with organizations that value insight-driven strategy, empowered execution, and genuine collaboration that delivers efficiently for patients. If you’re building or scaling a brand in a culture that prizes clarity, ownership, and results, I’d love to connect.
Driving Innovative Care Pathways & Precision Medicine for Alzheimer’s Patients Worldwide
Marketing lead for Ultra-orphan and Rare Disease Biologics, including hematology, immunology, and oncology new product development
Brand lead in neonatology for a rare disease biologic